FIELD: medicine.
SUBSTANCE: invention represents oral pharmaceutical preparative form for treatment and/or prevention of cancer, which includes (i) capsule, and (ii) core, including crystalline 2'-cyano-2'-deoxy-N4-palmitoyl-1-β-D- arabinofuranosylcytosine and liquid carrier, selected from triglyceride oil with average chain length and polyglycolised glyceride.
EFFECT: improvement of stability.
22 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CRYSTALLINE FORMS OF DERIVATIVE OF PYRIMIDINE NUCLEOSIDE (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR PROPHYLAXIS AND TREATMENT OF TUMOR DISEASE AND APPLYING CRYSTALLINE FORM | 2002 |
|
RU2256666C2 |
| PYRIMIDINE NUCLEOSIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2085557C1 |
| EMULSIFYING SYSTEMS CONTAINING AZETIDINE DERIVATIVES | 2004 |
|
RU2348615C2 |
| SEMIFIRM SYSTEMS CONTAINING DERIVATIVES OF AZETIDINUM | 2004 |
|
RU2343915C2 |
| NOVEL PYRIMIDINE NUCLEOSIDE OR SALT THEREOF | 2006 |
|
RU2395517C2 |
| PHARMACEUTICAL COMPOSITION BASED ON INDOMETHACIN MENTHYL ESTER IN FORM OF SOLID SELF-EMULSIFYING SYSTEM | 2023 |
|
RU2823982C1 |
| BENZIMIDAZOLYLPYRIDYL ESTER COMPOUNDS | 2007 |
|
RU2452469C2 |
| PYRIMIDINE NUCLEOSIDES, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2116306C1 |
| MICROEMULSION COMPOSITIONS INCLUDING SUBSTANCE P ANTAGONISTS | 2005 |
|
RU2397759C2 |
| β-L-2'-DEOXYNUCLEOSIDES USED IN HEPATITIS B TREATMENT | 1999 |
|
RU2300381C2 |
